The slip
PARKINSON RECEIPTno. 6506
22 Oct 2026, 14:07 UTCdopamine neurons, braak
predictionZNF229 in dopamine neurons tracks Braak Lewy-body stage
registered7a03d47d3ca1c624
discovery+0.21 p=0.588 n=9
replication+0.67 p=0.047 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.21, p 0.588)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTf208e99e45a3558553d1bc51…
follows fafb6ebf684d…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6506: ZNF229 in dopamine neurons, braak
- power
- full sample +0.50 (p 0.033, n 18), 95% CI +0.05 to +0.79. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.52 (p 0.027, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.50 (p 0.034, n 18). not the mix.
- skeptic
- leave-one-out range +0.42 to +0.59, sign flips 0; without severely affected donors +0.50 (p 0.033, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZNF229 in dopamine neurons.
case closed: nothing better to follow up.